Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)BCBS Vermont NMES Coverage Prior Auth | OpenPayer
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield of VermontPolicy 8.03.VT01

    Neuromuscular Electrical Stimulator (NMES) Corporate Medical Policy

    Customize your policy alerts

    Sign up for bcbsvermont Policy 8.03.VT01 alerts

    Get alerted when Policy 8.03.VT01 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and prior approval for therapeutic and functional neuromuscular electrical stimulation devices and related supplies. Therapeutic NMES may be considered medically necessary for specifically documented disuse atrophy and certain post-stroke rehabilitation uses, while specified functional NMES applications are investigational.

    Policy Summary
    PayerBlue Cross Blue Shield of Vermont
    PolicyNeuromuscular Electrical Stimulator (NMES) Corporate Medical Policy
    Policy CodePolicy 8.03.VT01
    Change TypeCoding table update
    Effective DateFeb 1, 2027
    Last ReviewOct 1, 2026
    Next Review DateOct 1, 2027
    Key ActionSubmit a complete prior approval request and verify the member's applicable benefit plan before requesting NMES services.
    SourceLink
    POLICY UPDATE CHANGES

    The October 2026 review removed non-applicable procedure and equipment codes from the coding table, including 63650, 63655, 63661-63664, 63685, 63688, 64575, 64580, 64581, 64585, 95970, 95971, L8680-L8683, L8685-L8689, A4560, and E0744.

    2NMES categories described

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3
    Disuse-atrophy treatment conditions listed
    RequiredAuthorization requirement
    3Investigational HCPCS codes
    4Investigational functional applications

    Coverage Criteria

    Therapeutic NMES medical necessity

    Therapeutic NMES devices may be considered medically necessary when all required clinical findings are documented and at least one qualifying condition is present.

    Required clinical findings and qualifying condition

    • Clinical findings

      • The request is for treatment of adequately documented disuse atrophy.
      • The nerve supply to the affected muscle is intact.
      • The medical record documents disuse atrophy based on physical examination.
      • Electromyography (EMG) documentation is submitted.
    • ONE qualifying condition

      • Recent hip surgery: Disuse atrophy results from recent hip surgery, and NMES is requested until the patient begins physical therapy.
      • Prolonged casting or splinting: Disuse atrophy results from casting or splinting of a joint for more than 12 weeks.greater than 12 weeks
      • Burn-related contractures: Contractures result from scarring of soft tissue from burns.
      • Partial paralysis following stroke: NMES is requested to improve wrist and finger function and prevent or correct shoulder subluxation in a person with partial paralysis following stroke.

    Investigational functional NMES uses

    The following functional NMES uses are considered investigational.

    • Upper-extremity function: Use to provide upper-extremity function in patients with nerve damage, including spinal cord injury or post-stroke nerve damage.
    • Foot-drop ambulation: Use to improve ambulation in patients with foot drop caused by congenital disorders such as cerebral palsy or nerve damage such as post-stroke injury or multiple sclerosis.
    • Spinal-cord-injury ambulation: Use as a technique to provide ambulation in patients with spinal cord injury.
    • Functional-electrical-stimulation exercycle: Use of an exercycle using functional electrical stimulation technology as physical therapy and exercise for a patient with spinal cord injury.

    Functional NMES used to restore function following nerve damage or nerve injury is considered investigational. This includes applications intended to provide upper-extremity function, improve ambulation for foot drop, provide ambulation after spinal cord injury, or deliver physical therapy and exercise through functional-electrical-stimulation exercycles.

    Coding and Code Status

    Codes considered medically necessary when applicable criteria are metHCPCSCovered
    A4595Electrical stimulator supplies, 2 lead, per month, (e.g., TENS, NMES)
    E0731Form fitting conductive garment for delivery of TENS or NMES (with conductive fibers separated from the patient's skin by layers of fabric)
    The following codes will be denied as InvestigationalHCPCS
    E0762Transcutaneous electrical joint stimulation device system.
    E0764Functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program.
    E0770Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified
    Codes removed from coding table in October 2026 reviewmixed
    63650Removed as a non-applicable code from the coding table.
    63655Removed as a non-applicable code from the coding table.
    63661Removed as a non-applicable code from the coding table.
    63662Removed as a non-applicable code from the coding table.
    63663Removed as a non-applicable code from the coding table.
    63664Removed as a non-applicable code from the coding table.
    63685Removed as a non-applicable code from the coding table.
    63688Removed as a non-applicable code from the coding table.
    64575Removed as a non-applicable code from the coding table.
    64580Removed as a non-applicable code from the coding table.
    1–10 of 25
    1/3
    Prolonged casting or splinting
    IndicationProlonged casting or splinting of a joint
    Duration thresholdGreater than 12 weeks
    Clinical contextDisuse atrophy resulting from prolonged casting or splinting

    Provider Actions and Decision Risks

    Prior Authorization

    Prior Approval Required

    Prior approval is required for NMES services. Benefits remain subject to all terms, limitations, and conditions of the member’s subscriber contract.

    Prior Authorization

    Prior Approval for Listed Supplies

    Prior approval is required for listed electrical-stimulator supplies and conductive garments when applicable.

    • A4595 — Electrical stimulator supplies, 2 lead, per month (for example, TENS or NMES).
    • E0731 — Form-fitting conductive garment for delivery of TENS or NMES.
    Documentation Required

    Background

    Neuromuscular electrical stimulation (NMES) uses electrical stimulation to activate muscles. Therapeutic NMES is intended to strengthen muscles weakened by disuse. Functional NMES uses microprocessor-controlled stimulation, often with an orthotic device, to attempt to restore functional movement when nerve pathways are damaged or destroyed. The policy distinguishes potentially medically necessary therapeutic treatment from functional restoration applications, which are considered investigational.

    Key Definitions

    Therapeutic NMES
    TermTherapeutic NMES
    DefinitionElectrical stimulation intended to strengthen muscles weakened by disuse.
    Primary purposeStrengthening muscles weakened by disuse
    Functional NMES
    TermFunctional NMES
    DeviceAn orthotic device with microprocessor-controlled electrical muscular stimulation
    PurposeAttempts to restore functional movement in patients with damaged or destroyed nerve pathways.

    Medical Necessity

    Therapeutic NMES DME medical necessity

    Therapeutic NMES may be considered medically necessary for DME when all documentation and clinical requirements are met.

    • Documented disuse atrophy

      • The device is used to treat adequately documented disuse atrophy.
      • The nerve supply to the affected muscle is intact.
      • The diagnosis is supported by physical examination.
      • EMG documentation is submitted.
    • ONE qualifying indication

    Documentation Requirements

    Documentation Required

    Document therapeutic NMES medical necessity

    Document therapeutic NMES medical necessity in the medical record. The record must show disuse atrophy based on physical examination and EMG findings, an intact nerve supply to the muscle, and one qualifying clinical condition.

    • Recent hip surgery until physical therapy begins
    • Joint casting or splinting greater than 12 weeks
    • Burn-related soft-tissue scarring with contractures
    • Partial paralysis following stroke requiring specified wrist, finger, or shoulder-subluxation treatment
    Documentation Required

    Submit complete prior authorization documentation

    Submit prior approval documentation that is complete and supports the requested service. Prior approval is required; incomplete requests may be delayed, and prior approval is also required for HCPCS A4595 and E0731.

    • Obtain prior approval for NMES services.
    • Include all required clinical and authorization information.
    • Obtain prior approval for A4595 electrical stimulator supplies and E0731 conductive garments.

    Investigational and Non-Covered Uses

    The following functional NMES applications are considered investigational and not covered as medically necessary: restoring upper-extremity function after nerve damage or injury, improving ambulation for foot drop caused by congenital disorders or nerve damage, providing ambulation for patients with spinal cord injury, and using functional-electrical-stimulation exercycles for physical therapy or exercise after spinal cord injury.

    Policy Summary
    PayerBlue Cross Blue Shield of Vermont
    PolicyNeuromuscular Electrical Stimulator (NMES) Corporate Medical Policy
    Policy CodePolicy 8.03.VT01
    Change TypeCoding table update
    Effective DateFeb 1, 2027
    Last ReviewOct 1, 2026
    Next Review DateOct 1, 2027
    Key ActionSubmit a complete prior approval request and verify the member's applicable benefit plan before requesting NMES services.
    SourceLink
    On This Page
    Coverage CriteriaCoding and Code StatusProvider Actions and Decision RisksBackgroundKey DefinitionsMedical NecessityDocumentation RequirementsInvestigational and Non-Covered Uses

    Document Diagnosis and Qualifying Condition

    For NMES in disuse atrophy, the medical record must document the member’s diagnosis based on physical examination and include supporting electromyography (EMG).

    • Document that the nerve supply to the muscle is intact.
    • Document adequately supported disuse atrophy and the associated qualifying condition.

    Unsupported block type: documentation

    Prior Authorization

    Verify Benefits and Submit a Complete Request

    Verify the member’s benefits and submit a complete prior-authorization request before providing NMES. Contract or benefit-plan language takes precedence when it conflicts with the medical policy.

    • Confirm coverage with the applicable member health plan, including NEHP/ABNE, FEP, and ASO arrangements when applicable.
    • Review the member’s group or individual contract and employer benefit-plan documents for exclusions or differing requirements.
    Denial Risk

    Functional Restoration Applications Are Investigational

    Neuromuscular stimulation is investigational when used to restore function following nerve damage or nerve injury, including affected-nerve upper-extremity function and ambulation applications.

    • Upper-extremity function in patients with nerve damage, including spinal cord injury or post-stroke conditions.
    • Ambulation for foot drop caused by congenital disorders or nerve damage, including poststroke or multiple sclerosis.
    • Ambulation in patients with spinal cord injury.
    • Functional electrical stimulation exercycles used for physical therapy or exercise in patients with spinal cord injury.
    Denial Risk

    Investigational HCPCS Codes

    Claims for the following HCPCS codes are denied as investigational under the coding table.

    • E0762 — Transcutaneous electrical joint stimulation device system.
    • E0764 — Functional neuromuscular stimulation for ambulation with computer control, used for walking by spinal cord-injured patients after completion of a training program.
    • E0770 — Functional electrical stimulator for transcutaneous stimulation of nerve or muscle groups, complete system, not otherwise specified.
    Denial Risk

    Insufficient Medical-Necessity Documentation

    Authorization may be denied when the medical record does not establish disuse atrophy and the applicable qualifying criteria. Ensure the diagnosis, physical-examination findings, EMG, and qualifying indication are documented.

    • The nerve supply to the muscle must be intact.
    • Document the qualifying condition and expected clinical improvement.
    Prior Authorization

    Incomplete Authorization Request

    Incomplete authorization requests may delay the decision while missing information is obtained. Submit all documentation needed to demonstrate the policy criteria.

    • Include the documented diagnosis, EMG and physical-examination support, qualifying indication, and applicable benefit information.
    Disuse atrophy
    TermDisuse atrophy
    DefinitionMuscle atrophy resulting from disuse, with an intact nerve supply to the muscle.
    Required documentationPhysical examination findings and electromyography (EMG), as applicable, must support the diagnosis.
    Qualifying contextThe condition must result from a qualifying circumstance identified in the policy.
  1. Recent hip surgery: Disuse atrophy follows recent hip surgery, and treatment is requested until the patient begins physical therapy.
  2. Prolonged casting or splinting: Disuse atrophy follows casting or splinting of a joint for more than 12 weeks.greater than 12 weeks
  3. Burn-related contractures: Contractures result from scarring of soft tissue from burns.
  4. Post-stroke partial paralysis: Treatment is requested to improve wrist and finger function and prevent or correct shoulder subluxation in a person with partial paralysis following stroke.